Cite this: The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the Plasma Cholesterol Level - Medscape - Jan 01, 2003.
A. W. (M. G. H. 728055), a 68-year-old domestic worker, was in excellent health until 1 month before admission to the hospital. At that time she became jaundiced; the stools became acholic, and ...
Compass Therapeutics' CTX-009 shows promise in biliary tract cancer, with a 37.5% response rate in phase 2 trials and a pivotal phase 2/3 readout expected in Q1 2025. Financially, CMPX is stable ...